by John R. Fischer
, Senior Reporter | September 07, 2021
Canon Medical Systems has teamed up with the National Cancer Center Japan and EAST Hospital in Kashiwa to further research on the use of photon-counting CT (PCCT).
PCCT is an advanced diagnostic imaging technique designed to identify multiple material components by measuring X-ray photons at different energy levels. Doing so enables it to enhance image resolution and quality, while reducing dose exposure compared to conventional CT.
Canon and the center’s Exploratory Oncology Research & Clinical Trial Center (NCC-EPOC) will use the quantitative capabilities of photon counting CT to assess treatment effects from chemotherapeutic agents on malignant tumors. They will also analyze different tissue characteristics for clinical insights on a wide range of medical fields.
KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at firstname.lastname@example.org to book a free demo.
"We hope our PCCT system will bring new clinical benefits to patients all over the world. These benefits are based on the identification of multiple material components, the higher resolution images, and lower exposure doses," Tomokazu Harada, a senior manager of CT marketing and promotion department for Canon Medical Systems, told HCB News.